Mulay James (CIK 1684531) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-16). Recent activity: Buy CGON (654 shares), Sell CGON (654 shares), Buy CGON (1,310 shares), Sell CGON (1,310 shares), Buy CGON (15,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-16 | CG Oncology, Inc. (CGON) | Director | Buy | 654 | $2,433 |
| 2026-06-16 | CG Oncology, Inc. (CGON) | Director | Sell | 654 | $39,318 |
| 2026-06-16 | CG Oncology, Inc. (CGON) | Director | Buy | 1,310 | $16,493 |
| 2026-06-16 | CG Oncology, Inc. (CGON) | Director | Sell | 1,310 | $78,757 |
| 2026-04-20 | CG Oncology, Inc. (CGON) | Director | Buy | 15,600 | $571,428 |
| 2026-04-20 | CG Oncology, Inc. (CGON) | Director | Sell | 15,600 | $1.1M |
| 2026-03-17 | CG Oncology, Inc. (CGON) | Director | Buy | 654 | $2,433 |
| 2026-03-17 | CG Oncology, Inc. (CGON) | Director | Sell | 654 | $41,529 |
| 2026-03-17 | CG Oncology, Inc. (CGON) | Director | Buy | 1,310 | $16,493 |
| 2026-03-17 | CG Oncology, Inc. (CGON) | Director | Sell | 1,310 | $83,185 |
| 2026-01-13 | CG Oncology, Inc. (CGON) | Director | Buy | 10,491 | $132,082 |
| 2026-01-13 | CG Oncology, Inc. (CGON) | Director | Sell | 654 | $28,881 |
| 2026-01-13 | CG Oncology, Inc. (CGON) | Director | Buy | 654 | $2,433 |
| 2026-01-13 | CG Oncology, Inc. (CGON) | Director | Sell | 10,491 | $555,918 |
| 2025-10-10 | CG Oncology, Inc. (CGON) | Director | Buy | 5,903 | $21,959 |
| 2025-10-10 | CG Oncology, Inc. (CGON) | Director | Sell | 5,903 | $259,673 |
| 2025-09-30 | CG Oncology, Inc. (CGON) | Director | Buy | 12,755 | $23,214 |
| 2025-09-30 | CG Oncology, Inc. (CGON) | Director | Sell | 12,755 | $499,868 |
| 2025-09-22 | CG Oncology, Inc. (CGON) | Director | Buy | 19,112 | $34,784 |
| 2025-09-22 | CG Oncology, Inc. (CGON) | Director | Sell | 19,112 | $745,559 |
| 2025-09-22 | CG Oncology, Inc. (CGON) | Director | Buy | 3,574 | $6,505 |
| 2025-09-22 | CG Oncology, Inc. (CGON) | Director | Sell | 3,574 | $139,350 |
| 2025-09-08 | CG Oncology, Inc. (CGON) | Director | Buy | 27,015 | $16,209 |
| 2025-09-08 | CG Oncology, Inc. (CGON) | Director | Sell | 12,342 | $376,061 |
| 2025-09-08 | CG Oncology, Inc. (CGON) | Director | Sell | 4,095 | $128,665 |
Source: SEC Form 4 filings · as of 2026-06-16